Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries.
Saved in:
| Title: | Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries. |
|---|---|
| Authors: | Aymon R; Department of Rheumatology, Geneva University Hospital, Geneva, Switzerland., Mongin D; Department of Rheumatology, Geneva University Hospital, Geneva, Switzerland., Guemara R; Department of Rheumatology, Geneva University Hospital, Geneva, Switzerland., Salis Z; University of Montpellier and Physiology and Experimental Medicine of the Heart and Muscles, Montpellier, France., Askling J; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Choquette D; Centre Hospitalier de l'Université de Montréal, Institut de Recherche en Rhumatologie, Montréal, Québec, Canada., Codreanu C; University of Medicine, Center of Rheumatic Diseases, Bucharest, Romania., Di Giuseppe D; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Flouri I; Rheumatology and Clinical Immunology, University Hospital of Heraklion, Crete, Greece., Huschek D; Deutsches Rheuma-Forschungszentrum, Programme Area Epidemiology, Berlin, Germany., Hyrich KL; National Institute for Health and Care Research Manchester Biomedical Research Centre, Manchester University NHS Trust, Manchester, United Kingdom., Iannone F; Department of Precision and Regenerative Medicine and Ionian Area, Rheumatology Unit University of Bari, Bari, Italy., Kvien TK; Diakonhjemmet Hospital, Center for Treatment of Rheumatic and Musculoskeletal Diseases, Oslo, Norway., Leeb BF; BioReg, Vienna, Austria., Nordström D; Departments of Medicine and Rheumatology, Helsinki University Hospital, The National Register of Biological Medicines, Helsinki, Finland., Otero-Varela L; Research Unit, Spanish Society of Rheumatology, Madrid, Spain., Pavelka K; Institute of Rheumatology, Prague, Czech Republic., Pombo-Suarez M; NOVA Medical School, Universidade Nova de Lisaboa, Lisbon, Portugal., Rodrigues A; NOVA Medical School, Universidade Nova de Lisaboa and Reuma.pt, Sociedade Portuguesa de Reumatologia, Lisbon, Portugal., Rotar Z; Department of Rheumatology, University Medical Centre Ljubljana & Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Sidiropoulos P; Rheumatology and Clinical Immunology, University Hospital of Heraklion, Crete, Greece., Provan SA; Diakonhjemmet Hospital, Center for Treatment of Rheumatic and Musculoskeletal Diseases, Oslo, Norway., Strangfeld A; Deutsches Rheuma-Forschungszentrum, Programme Area Epidemiology and Charité - Universitätsmedizin, Berlin, Germany., Nina T; Departments of Medicine and Rheumatology, Helsinki University Hospital, The National Register of Biological Medicines, Helsinki, Finland., Zavada J; Institute of Rheumatology, Prague, Czech Republic., Kearsley-Fleet L; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom., Courvoisier DS; Department of Rheumatology, Geneva University Hospital, Geneva, Switzerland., Finckh A; Department of Rheumatology, Geneva University Hospital and Geneva Center for Inflammation Research, University of Geneva, Geneva, Switzerland., Lauper K; Department of Rheumatology, Geneva University Hospital, Geneva, Switzerland. |
| Source: | Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2025 Sep; Vol. 77 (9), pp. 1194-1204. Date of Electronic Publication: 2025 May 21. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2326-5205 |
|---|---|
| DOI: | 10.1002/art.43188 |
